NCT07084129View on ClinicalTrials.gov

Vancomycin and Acute Kidney Injury in Sepsis Treatment - Intervention

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

August 15, 2026

Study Completion Date

December 31, 2026

Conditions
Sepsis
Interventions
OTHER

personalized dosing adjustment of vancomycin

A personalized vancomycin PK model that incorporates kidney injury biomarkers will be used for vancomycin dose adjustments to achieve goal AUC levels.

Trial Locations (1)

19104

RECRUITING

Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Children's Hospital of Philadelphia

OTHER